enGene Ownership | Who Owns enGene?
enGene Ownership Summary
enGene is owned by 71.37% institutional investors, 0.10% insiders, and 28.53% retail investors. Fcpm iii services b.v. is the largest institutional shareholder, holding 13.82% of ENGN shares. Polar Capital Biotech S Inc is the top mutual fund, with 1.73% of its assets in enGene shares.
ENGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | enGene | 71.37% | 0.10% | 28.53% |
| Sector | Healthcare Stocks | 50.53% | 12.40% | 37.07% |
| Industry | Biotech Stocks | 48.96% | 12.12% | 38.92% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fcpm iii services b.v. | 9.63M | 13.82% | $16.66M |
| Adage capital partners gp | 1.00M | 1.96% | $6.83M |
| Omega fund management | 876.36K | 1.30% | $5.97M |
| Sr one capital management, lp | 747.75K | 1.11% | $5.09M |
| Sphera funds management | 504.41K | 0.99% | $3.45M |
| Quadrature capital | 33.80K | 0.05% | $230.16K |
| Toronto dominion bank | 10.00K | 0.02% | $68.30K |
| Cresset asset management | 10.00K | 0.02% | $68.30K |
| Renaissance | - | - | - |
| Birchview capital, lp | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Omega fund management | 876.36K | 3.66% | $5.97M |
| Fcpm iii services b.v. | 9.63M | 2.22% | $16.66M |
| Sphera funds management | 504.41K | 0.73% | $3.45M |
| Sr one capital management, lp | 747.75K | 0.56% | $5.09M |
| Adage capital partners gp | 1.00M | 0.01% | $6.83M |
| Quadrature capital | 33.80K | 0.00% | $230.16K |
| Cresset asset management | 10.00K | 0.00% | $68.30K |
| Toronto dominion bank | 10.00K | 0.00% | $68.30K |
| Renaissance | - | - | - |
| Birchview capital, lp | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cresset asset management | 10.00K | 0.00% | - |
| Adage capital partners gp | 1.00M | 0.01% | - |
| Fcpm iii services b.v. | 9.63M | 2.22% | - |
| Sr one capital management, lp | 747.75K | 0.56% | - |
| Omega fund management | 876.36K | 3.66% | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Perceptive advisors | - | - | -5.83M |
| Siren | - | - | -5.25M |
| Vr adviser | - | - | -4.77M |
| Blue owl capital lp | - | - | -4.42M |
| Deep track capital, lp | - | - | -4.38M |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -28.00 |
| Citigroup | -99.00 |
| Caitong asset management | -163.00 |
| Barclays | -342.00 |
| Nbc securities | -380.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 66 | 11.86% | 49,763,286 | -10.82% | 71 | 1.11% | 36 | 5.88% | 17 | 21.43% |
| Mar 31, 2026 | 59 | 3.51% | 55,801,630 | -4.94% | 82 | 0.63% | 34 | -20.93% | 14 | 75.00% |
| Dec 31, 2025 | 27 | -28.95% | 17,021,462 | -58.35% | 33 | 0.52% | 21 | 50.00% | 2 | -75.00% |
| Sep 30, 2025 | 38 | 2.70% | 40,868,497 | 1.11% | 79 | 1.27% | 14 | 7.69% | 8 | -11.11% |
| Jun 30, 2025 | 37 | 19.35% | 40,420,485 | -1.27% | 79 | 1.23% | 13 | 44.44% | 9 | 12.50% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Polar Capital Biotech S Inc | 1.16M | 1.73% | - |
| Eventide Healthcare & Life Sciences I | 950.00K | 1.42% | 950.00K |
| Franklin Biotechnology Discv A(acc)USD | 828.41K | 1.24% | - |
| Franklin Biotechnology Discovery A | 486.58K | 0.73% | - |
| Fidelity Select Biotechnology | 232.20K | 0.35% | - |
| Kennedy Micro Cap | 172.26K | 0.26% | -133.17K |
| Kennedy Micro Cap Opportunities | 76.20K | 0.11% | -44.15K |
| Virtus LifeSci Biotech Clinical Trls ETF | 39.01K | 0.06% | - |
| Avantis US Small Cap Equity ETF | 26.75K | 0.04% | - |
| Protea Sectoral Biotech Opps IF USD Acc | 21.70K | 0.03% | 21.70K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $5.00M |
| Oct 07, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $77.53K |
| Oct 04, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $39.24K |
| Oct 03, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $37.40K |
| Oct 08, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A. | - | Buy | $5.28K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
ENGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools